◆ 会议时间：2025年6月17-21日
◆ 会议地点：瑞士 卢加诺（Lugano, Switzerland）

◆ 会议简介：

2025年第18届恶性淋巴瘤国际会议(18-ICML)将于2025年6月17-21日在瑞士卢加诺举行。

国际恶性淋巴瘤会议(ICML)是全球最大的恶性淋巴瘤国际会议，自1981年召开第一次会议以来，ICML已成为从事淋巴肿瘤研究与治疗的科学界的一项重要活动，大会将介绍和讨论有关淋巴瘤最新的基础、转化、临床研究成果。ICML由(瑞士)肿瘤研究所基金会(IOR)组织，并与美国癌症研究协会(AACR)与欧洲肿瘤学院(ESO)合作，通过一个由淋巴瘤专家组成的小组宣编制的特别科学计划方案，ICML为其参与者提供了一个了解最新研究结果的机会。ICML会议每两年在卢加诺(瑞士)举行一次，汇集了来自世界各地的近3500名医生和科学家代表，包括血液学家，临床肿瘤学家，放射肿瘤学家，儿科医生，病理学家和参与淋巴样肿瘤研究和治疗的研究人员。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

18-ICML
18th International Conference on Malignant Lymphoma (ICML)

Date: June 17-21, 2025
Location: Lugano, Switzerland

The International Conference on Malignant Lymphoma (ICML) was first held in 1981 in Lugano, and since then it has never failed in providing an unique opportunity for the international community involved in the research and treatment of hematologic malignancies to share, debate and update their knowledge and expertise.

摘要征文投稿：

Abstract submission deadlines
 

点此提交摘要>>>Submit Abstract>>>

TEXT

May not exceed 3000 characters (including spaces).

All abstracts (except for Ongoing Trials abstracts) should include the following four sections:

• Introduction;
• Methods;
• Results;
• Conclusions.

Drugs should be mentioned with the generic name in lower case. Commercial names must not be used.

Abbreviations are permitted but terms must be spelt out at their first mention in the text and followed by the abbreviation in parentheses, i.e. International Conference on Malignant Lymphoma (ICML).
 

IMAGE, GRAPH OR TABLE
One image, graph or table can be submitted, as a separate file.
The system accepts only one file, up to 10 MB.
JPEG, GIF or PNG files can be uploaded, with the following resolution criteria:

• Graphs and tables: 800 dpi preferred; 600 dpi minimum;
• Images: 300 dpi minimum.

Images, graphs and tables without readable text may be removed from the Abstract Book without further recourse to the authors.

RESEARCH FUNDING DECLARATION
Disclose of commercial, public, or private foundation grants.

CATEGORIES
(minimum 1 – maximum 3), to be selected from the "Abstract Categories list", available here:

Abstract Categories list

ENCORE ABSTRACTS
Only abstracts submitted and published and/or presented at the following international meetings, which are organised in the same period as 18-ICML (March - June 2025), can be submitted to the 18-ICML:

• EBMT (European Bone Marrow Transplant), 30 March - 2 April 2025;
• AACR (American Association for Cancer Research), 25 - 30 April 2025;
• ASCO (American Society of Clinical Oncology), 30 May – 3 June 2025;
• EHA (European Hematology Association), 12 – 15 June 2025.

In addition, encore abstracts will be accepted if they have been submitted and published and/or presented at regional or national meetings with up to 1000 attendees.
The Encore abstract checkbox must be ticked at the time of submission.
 

UPDATED ANALYSIS
Abstracts published and/or presented at other international meetings than EBMT, AACR, ASCO, EHA 2025 will be considered only if significant novel information is added to previous publications.
At the time of submission, the previous publication and the novel information can be indicated in the “Updated Analysis” field.
 

ONGOING TRIAL ABSTRACTS
Abstracts describing trials in progress can be submitted, provided that patient enrollment has already started at the time of submission.
Ongoing trials abstracts are required to include Introduction and Methods sections only (no results or preliminary data must be included).
Only the scientific and clinical rationale of the trial will be evaluated.
The “Ongoing Trial” checkbox must be ticked at the time of submission.
 

PREFERRED PRESENTATION FORMAT
At the time of submission, the preferred presentation format can be selected:

• oral presentation (general sessions and “Focus on…” sessions);
• poster presentation;
• no preference.

The Organising Committee reserves the right to ultimately decide the presentation format, taking into account the evaluation results and the structure of the Scientific Programme.

OPT-OUT FROM ABSTRACT BOOK (in case of selection for “Publication only”)
All abstracts that have been selected for oral or poster presentation will be included in the 18-ICML Abstract Book.

Abstracts selected for “publication only” will be included in the 18-ICML Abstract Book, unless explicitly indicated at the time of submission by ticking the “Opt-out from Abstract Book” checkbox.

APPLICATION FOR A TRAVEL GRANT
Subject to funding availability, a limited number of travel grants will be awarded to young investigators (under 35 years old), designated as the presenting authors of the abstracts accepted for oral or poster presentation.
The selection will be made based on the abstract evaluation results.

Eligible presenting authors can apply for the travel grant at the time of abstract submission by selecting the “Travel grant” check box.

ADDITIONAL CONTACT EMAIL
in addition to the Submitter (who is the primary contact), the additional contact will receive all notifications concerning the evaluation outcome and future correspondence regarding the abstract.

ACCEPTANCE OF SUBMISSION REQUIREMENTS AND AUTHORS’ RESPONSIBILITIES
(see the relevant page).

Corrigenda
Once the abstract has been submitted, corrigenda (corrections, rewording or amendments to the text and change of order of the list of authors) cannot be made.

If an error in a submitted abstract is discovered after the deadline, the presenting author may draw attention to the correction during the presentation (in the case of acceptance of the abstract for oral or poster presentation).
The ICML Secretariat is not authorised to make changes to a submission.

Withdrawal policy
No abstract withdrawal request will be accepted after the submission deadline.

注册费：

* Professional category certificate required.

**After 11 June 2025, only payment by credit card will be accepted.

The in-person registration fee includes:
 

- access to all the Scientific sessions:

• 3 Keynote Lectures;
• 12 Meet the Professor sessions (8 repeated twice);
• 2 Educational Symposia;
• AACR-ICML joint session;
• “Focus on…” sessions;
• Clinical cases discussion sessions;
• general, special and joint sessions;
• access to the Industry Programme*;
• live streaming of the Scientific and Industry Programmes*;
• on-demand streaming of the Scientific and Industry Programmes*, available until 12 December, 2025;
• access to the Poster Area and the E-poster gallery;
• access to the Exhibition area and to the Virtual exhibition area;
• Educational Book available on the Wiley Library website from Sunday 15 June at 23:59 CEST;
• Abstract Book (supplement of “Hematological Oncology” - John Wiley and Sons, Inc.) available on the Wiley Library website from Sunday 15 June at 23:59 CEST;
• programme book with the conference schedule and useful information on the venue;
• Q&A tool;
• Welcome refreshment on 17 June;
• lunches and refreshment breaks on 18, 19 and 20 June;
• Farewell aperitif on June 20;
• Congress bag.

- live and on-demand streaming.

*unless otherwise specified by the organising companies and agencies

Virtual registration fee includes:

• live streaming of the Scientific and Industry Programmes*;
• on-demand streaming of the Scientific and Industry Programmes*, available until 12 December 2025;
• Abstract Book (supplement of “Hematological Oncology” - John Wiley and Sons, Inc.) and Educational Book will be available on the Wiley Library website from Sunday 15 June at 23:59 CEST;
• access to the E-poster gallery;
• access to the Virtual exhibition area;
• Q&A tool.

*unless otherwise specified by the organising companies and agencies.

◆ 参会对象：
临床肿瘤学家/医生，放射肿瘤学家，儿科医生，病理学家和参与淋巴样肿瘤研究和治疗的研究人员，以及其他对该领域感兴趣的相关专业人士等等。